New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT03433898
First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 20 times
Summary
This early-phase study tested a new immunotherapy drug (BI 754091) alone or combined with another drug (BI 754111) in 146 Asian patients with advanced solid tumors like stomach, liver, and lung cancer. The main goals were to find safe doses and check for side effects. Researchers also looked for signs that the tumors shrank. This is not a cure but aims to help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Chang Gung Memorial Hospital(Linkou)
Taoyuan, 333, Taiwan
-
Japanese Foundation for Cancer Research
Tokyo, Koto-ku, 135-8550, Japan
-
Kanagawa Cancer Center
Kanagawa, Yokohama, 241-8515, Japan
-
NCKUH
Tainan, 70403, Taiwan
-
National Cancer Center Hospital
Tokyo, Chuo-ku, 104-0045, Japan
-
National Cancer Center Hospital East
Chiba, Kashiwa, 277-8577, Japan
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
Saitama Cancer Center
Saitama, Kitaadachi-gun, 362-0806, Japan
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital
Seoul, 03722, South Korea
-
Shizuoka Cancer Center
Shizuoka, Sunto-gun, 411-8777, Japan
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
Conditions
Explore the condition pages connected to this study.